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Tumor angiogenesis was simulated using a two-dimensional
computational model. The equation that governed angiogenesis
comprised a tumor angiogenesis factor (TAF) conservation
equation in time and space, which was solved numerically
using the Galerkin finite element method. The time derivative
in the equation was approximated by a forward Euler scheme.
A stochastic process model was used to simulate vessel
formation and vessel elongation towards a paracrine site, i.e.,
tumor-secreted basic fibroblast growth factor (bFGF). In this
study, we assumed a two-dimensional model that represented
a thin (1.0 mm) slice of the tumor. The growth of the tumor
over time was modeled according to the dynamic value of
bFGF secreted within the tumor. The data used for the model
were based on a previously reported model of a brain tumor
in which four distinct stages (multicellular spherical, first
detectable lesion, diagnosis, and death of the virtual patient)
were modeled. In our study, computation was not continued
beyond the 'diagnosis' time point to avoid the computational
complexity of analyzing numerous vascular branches. The
numerical solutions revealed that no bFGF remained within the
region in which vessels developed, owing to the uptake of
bFGF by endothelial cells. Consequently, a sharp declining
gradient of bFGF existed near the surface of the tumor. The
vascular architecture developed numerous branches close to the
tumor surface (the brush-border effect). Asymmetrical tumor
growth was associated with a greater degree of branching at
the tumor surface.
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INTRODUCTION
Despite substantial progress in therapeutic
efforts, the outcome of some malignant cancers re-
mains very poor. Novel therapies are being devel-
oped, one of which is a method to suppress cancer
angiogenesis that was proposed by Folkman
1 and
others.
There have been many modeling studies of
tumor angiogenesis in which continuous or dis-
crete models were used. In continuous models,
only the distribution of enthothelial cells is
considered; vascular networks are not included.
Chaplain et al.
2,3 presented two- and three-dimen-
sional models of tumor angiogenesis using a
combination of both the discrete and continuous
method. To determine the movement of the
sprouting tips of enthothelial cells, the authors
solved partial differential equations of the concen-
tration of a tumor angiogenesis factor (TAF),
fibronectin concentrations, and endothelial cell
density using the finite difference method. The
formation and growth of vessel sprouts were
approximated using a stochastic process that was
based on the distribution of TAF and fibronectin.
Chaplain et al.
2,3 also assumed that TAF secretion
was constant over time. The numerical solutions
of such models can be compared to experimental
data, and cellular mechanisms can be incor-
porated readily into new mathematical models.
Lastly, Gazit et al.
4 used fractal theory to compute
the vessel networks that surrounded a tumor and
computed the hemodynamics within the vessel
structures.
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MATERIALS AND METHODS
Previous works
Recently, Tong et al.
5 developed a two-dimen-
sional model of angiogenesis in which they
assumed a biased random motion of endothelial
cells. To obtain basic information about the
biased growth of endothelial cells, the authors
examined the transport of angiogenic factors in
rat cornea. Because vessel growth in their study
was independent of the computation mesh
(unlike Chaplain's model), tumor angiogenesis
was implemented in a more realistic and efficient
manner. However, one of the main problems
with previous models is that the quantity of
angiogenic factors that are released from tumor
cells is assumed to be constant. This assumption
is unrealistic because as the volume of a tumor
increases, the quantity of angiogenic factors that
are released also increases.
In the present study, we present a computatio-
nal model of tumor-induced angiogenesis for a
growing brain tumor, based on Tong's model.
5
However, in contrast to Tong's and other
models, our model includes dynamic (time-
varying) release of angiogenic factors from tumor
cells. The model of the growing brain tumor that
we used was adopted from the work of Kansal
et al.
6 The quantity of TAF released from a
growing brain tumor depends on the volume of
the tumor and the number of constituent cells.
We selected basic fibroblast growth factor (bFGF)
as a TAF, because the concentration of bFGF is
reportedly proportional to the increase in malig-
nancy and vascularity of high-grade gliomas.
7,8
Some parameter values for bFGF-induced angio-
genesis were obtained from Tong et al.,
6 and we
used 50 pg/10
5 cells per 24 h as the production
rate for bFGF by human U87 glioma cells.
9 The
finite element method was used to solve the
convection-diffusion equation for the concentra-
tion of bFGF. This method is a convenient way
with which to deal with the complex geometry
of real biological phenomena. Both vessel forma-
tion and sprout elongation were simulated using
a stochastic process as in the aforementioned
studies.
Model
Algorithm
Transport equation for basic fibroblast growth factor
The transport of bFGF within tissue depends on
the diffusion of this molecule into the interstitial
space, uptake of bFGF by endothelial cells, and
chemical inactivation of bFGF within the extracel-
lular space. The partial differential equation of
bFGF transport is represented in Eq. (1), which
was obtained from Tong et al.
5
(1)
In Eq. (1), C, D, k, u, and L represent the
concentration of bFGF, the diffusion coefficient of
bFGF, the rate constant of bFGF degradation, the
rate constant of bFGF uptake, and vessel density
(defined as the total vessel length per unit area),
respectively. For the computational domain,
application of the Galerkin finite element dis-
cretization for Eq. (1) yielded the following
matrix equation.
KX=R (2)
In this matrix, K is the stiffness matrix, X is the
vector of unknown nodal variables of C, and R
contains the external driving forces. The matrix
Eq. (2) was solved using an incomplete conjugate
gradient method.
10
Sprout formation and elongation
The initial response of the endothelial cells to
bFGF is chemotactic, and this initiates the migra-
tion of endothelial cells towards the bFGF-re-
leasing tumor. Thereafter, small capillary sprouts
are formed. The sprouts increase in length owing
to the migration and recruitment of endothelial
cells. The sprouts continue to grow towards the
growing tumor, guided by the motion of the
leading endothelial cell at the tip of the sprout.
First, we introduced a threshold function f(C) to
account for the effect of concentration of bFGF on
sprout formation and elongation, as follows.
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In Eq. (3), Ct is the threshold concentration and
α is a constant that controls the shape of the
curve.
To approximate sprout formation, we assumed
it to be a stochastic process. The probability n ⁻ for
the formation of one sprout from a vessel segment
in a time interval between t and t+ t is pro-
portional to t, the segment length l, and the
threshold function, as follows:
(4)
In Eq. (4), Smax is a rate constant that deter-
mines the maximum probability of sprout forma-
tion per unit time and vessel length.
The growth of a sprout is determined by the
locomotion of its tip, while the geometry of a
sprout depends on the tip trajectory.
10 The
direction of sprout growth at each time step
depends on two unit vectors: the direction of
growth in the previous time step and the direction
of the concentration gradient of the angiogenic
factors. This is because sprout growth depends on
endothelial cell migration, which has a tendency
to persist in the same direction as in the previous
time step. To reflect the effect of the extracellular
matrix on cell migration, we assumed that the
angle of deviation, , was between 90 and -90 θ
and that tan had a Gaussian distribution with a
mean of zero and a variance of σ
2. A detailed
description of sprout formation and elongation
can be found in the reference.
5
Brain tumor growth model
We used a model of a brain tumor that had four
distinct growth stages, namely spherical, detec-
table lesion, diagnosis, and death.
6 To approxi-
mate data in each of these growth stages, we used
the following Gompertz equation:
(5)
In Eq. (5), A and B are parameters and is the
initial volume. The quantity of bFGF release at
each of the four stages is summarized in Table 2.
We assumed that tumor growth was spherical and
investigated a 1.0-mm-thick, circular slice of the
tumor for our two-dimensional model. As both
the proliferative and quiescent tumor cell fractions
likely release bFGF, we calculated the amount of
bFGF at each of the four stages for the total
amount of living tumor cells using the cell
numbers reported by Kansal et al.
6
Analysis
Two-dimensional simulation model
The two-dimensional model is depicted in Fig.
1. In Fig. 1, Ldomain, RPV and Rt represent the
distribution of bFGF, the radius of the parent
vessel measured from the center of the tumor, and
the tumor radius, respectively. We assumed that
the radius of the tumor increased over time and
calculated the tumor radius using Eq. (6).
Table 1. Values of Model Constants for the Standard Case of Tumor Growth
Constant Value
Diffusion coefficient for bFGF D 0.5×10
-6cm
2 s
-1
Rate constant of uptake U 2000.0 mh μ
-1
Threshold concentration C
t 0.001
Variance of deviation angle S
2 0.5
Rate constant of sprout formation Smax 5×10
-4 m μ
-1h
-1
Rate constant of bFGF degradation K 2.89×10
-2h
-1
Shape constant in the threshold function α 10
Persistence ratio P 0.5
Maximum rate of sprout length increase Vmax 20 mh μ
-1( )÷
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(6)
In Eq. (6), R0 was assumed to be 1.0 mm as an
initial condition. RPV was selected to allow the
first branch to reach the source at a time point at
which the tumor radius was 1.0 mm.
11 We found
that a lattice disk with a radius of 4.5 mm satisfied
this condition, and Ldomain was assumed to cover
the disc. We also assumed that bFGF was released
continually from the tumor, which was located at
the center of the aforementioned disk (i.e., repre-
sented as a solid circle in a transverse section of
the tumor). The region into which angiogenic
factors diffused was a 10.0×10.0-mm square
(Ldomain=10.0 mm). Three points of initial sprouting
were located between 180 and 270 .
Initial and boundary conditions
To solve the equation that governed the
concentrations of angiogenic factors (Eq. (1)), a 'no
flux' condition was assumed for bFGF transport at
the boundary of the diffusion region. The initial
Table 2. Approximate Concentration of Basic Fibroblast Growth Factor (bFGF) Released during Each of the Four
Consecutive Growth Stages Used to Simulate Growth of a Brain Tumor (based on Ref. 6).
Growth Stage
Spheroid 1st Detectable lesion Diagnosis Death
Volume (V) 0.5236 μl 523.6 μl 26521.85 μl 65449.847 μl
Radius (R) 0.5 mm 5 mm 18.5 mm 25 mm
Slice volume (Vs= R π
2t)
t=slice thickness (=0.1.0 mm)
0.07854 μl 7.854 μl 107.521.0 μl 196.35 μl
Proliferative and quiescent cell
volume per slice (cell fraction)
0.0424 μl
(54%)
4.0 μl
(51%)
48.4 μl
(45%)
78.5 μl
(40%)
Elapsed time of tumor growth
(simulation results
6)
69 days 223 days 454 days 560 days
Total number of cells (Ntotal) 10
6 10
9 5 × 10
10 10
11
No. of cells per slice volume
(Nslice)
1.5 × 10
5
(10
6 × 0.07854/0.5236)
1.5×10
7
(10
9×7.854/523.6)
2.02 × 10
8
(5 × 10
10 × 107.521
/26521.8)
3.0 × 10
8
(10
11 × 196.35
/65449.85)
Proliferative and quiescent cell
numbers in slice volume
Nviable=(red+yellow cell
fraction)× Nslice
8.1 × 10
4 7.65×10
6 9.09 × 10
7 1.2 × 10
8
bFGF production rate from
Nviable tumor cells
40.5 pg/24 h
(8.1 × 10
4 × 50/10
5)
3,825 pg/24 h
(7.65 × 10
6 × 50/10
5)
45,450 pg/24 h
(9.12 × 10
7 × 50/10
5)
60,000 pg/24 h
(1.2 × 10
8 × 50/10
5)
Fig. 1. Two-dimensional model geometry for the standard
case of symmetrical tumor growth. Radii are depicted as
described in the text. To facilitate computation, the geo-
metric growth of the central (gray) tumor circle was not
calculated. This figure also illustrates the region of
interest (ROI) and branching point.Two-dimensional Model of Tumor Angiogenesis Patterns
Yonsei Med J Vol. 46, No. 2, 2005
concentration of bFGF was zero within the com-
putational region. For computational convenience,
we assumed that the initial radius of the tumor
was 0.1 mm. The concentration of bFGF at the
tumor site increased with the tumor volume,
which concurs with a cellular automaton model
described previously, in which a growing brain
tumor was simulated over several orders of
magnitude.
6 Table 2 shows the rate of bFGF
production over time. For the space discretization
of the computational domain, a 200 × 200 finite
element lattice was used and linear approxima-
tions of the variables within elements were
assumed. We calculated both symmetrical and
asymmetrical tumor growth.
For asymmetrical tumor growth, we assumed
that tumor growth was symmetrical before the
first vessel branch made contact with the tumor
surface; thereafter, growth was assumed to be
asymmetrical (see Eq. (7)). As represented in Fig.
2, the vessel branch contacted the tumor surface
when R=1.0 mm (T1 tumor with center point C1),
after which the tumor began to grow eccentrically.
The eccentricity L at time t (T2 tumor with center
point C2) owing to asymmetrical tumor growth
was defined as follows:
L=(t-tref)Vecc if t > tref (7)
In Eq. (7), t and tref represent the arbitrary time
and reference time at which the first vessel branch
made contact with the tumor surface, respectively.
According to the preliminary computation, tref
was -2,600 h. Vecc is a variable that represents the
rate of eccentricity change; therefore, the eccentric
distance at a time t can be expressed as Eq. (7).
In this study, we assumed that Vecc=0.003 mm/h.
The direction of eccentricity was 225 . In the equa-
tion above, note that only the part of the tumor
that was facing the blood vessels grew.
Branching pattern analysis
To quantify the vessel branching pattern within
the computational domain, we calculated the
number of branching points within a given region
of interest (ROI). A ROI was defined as 50 circular
areas that divided the space between the central
tumor domain and the circle from which the
parent vessel originated (see Fig. 1). A branching
point was defined as the site at which one vessel
was divided into two new vessels (Fig. 1). For
each ROI, the total number of branching points
within the ROI was calculated according to the
average distance of the ROI from the parent
vessel. To take into account temporal variation of
vessel growth, we considered the total length of
vessels at certain time points (equivalent to the
sum of the lengths of all vessels that existed at
that point in time).
RESULTS
First, we computed a standard case for the
parameters as shown in Table 1. Dynamic changes
in the tumor radius and the concentration of bFGF
(Fig. 3) were computed from Eq. (6). Compared to
the tumor radius, the concentration of bFGF had
a sharper gradient after t=3,000 h. The concentra-
tion distribution over time of bFGF (Fig. 4) re-
vealed that the concentration distribution of bFGF
was a radial isotropic gradient at t=1,656 h
(spherical state), because the bFGF excreted from
the tumor diffused spatially in all directions and
only very short branches existed close to the par-
ent vessel. As the branched vessels grew toward
the tumor surface, bFGF consumption occurred
around these vessels. The radial gradient of the
concentration distribution of bFGF ceased to vary
isotropically; the concentration of bFGF was very
Fig. 2. Two-dimensional model geometry for asymmetri-
cal tumor growth.Eun Bo Shim, et al.
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low on the side on which the vessels were
growing and was relatively high on the side op-
posite to the parent vessel (Fig. 4(B) and (C)).
The vessel branching pattern for symmetrical
tumor growth is shown in Fig. 5. Initially, three
branches from the parent vessel grew toward the
tumor following the concentration gradient of
bFGF. The lowest branch appeared to be very
short initially, but subsequently branched numer-
ous times as it approached the tumor surface. In
our simulation, the first vessel branch touched the
tumor surface at t=2,590 h; this vessel branching
pattern is exemplified by the pattern in Fig. 5(B),
which illustrates the branching pattern at t=2,600
h. At t=3,200 h, there were numerous vessel
branches close to the tumor surface (the brush-
border effect; Fig. 5(C)).
The pattern of vessel growth for symmetrical
tumor growth is illustrated in Fig. 6. At t=1565
and t=2600 h, the number of branching points
near the tumor surface was largely unchanged,
whereas at t=2800 and t=3000 h, there was a
marked increase in the number of branching
points near the tumor surface. The total vessel
length was relatively constant initially, but in-
creased sharply after the first vessel reached the
tumor surface at t=2,590 h (Fig. 7).
Asymmetrical tumor growth is illustrated in
Fig. 8 and 9. Unlike symmetrical tumor growth,
asymmetrical growth was associated with slightly
elevated concentrations of bFGF at the tumor sur-
face (Fig. 8), which acted as promoter that en-
hanced branching of the parent vessel. Never-
theless, the difference in the concentration of
bFGF during symmetrical and asymmetrical
growth was small. Fig. 9 illustrates that asym-
metrical tumor growth was biased toward the
Fig. 3. Radius of the tumor and concentration of basic
fibroblast growth factor (bFGF) over time.
Fig. 4. Contours of concentration gradient for bFGF
(relative to bFGF concentration for a tumor radius of 1.0
mm at t=2,590 h) over time for the standard case of sym-
metrical tumor growth. (A) t=1,656 h (spherical growth
stage). (B) t=2,600 h. (C) t=3,000 h.
A
B
CTwo-dimensional Model of Tumor Angiogenesis Patterns
Yonsei Med J Vol. 46, No. 2, 2005
parent vessel. Although the pattern of vessel
branching was similar to the case of symmetrical
growth, branches generated from the lowest
location of the parent vessel during asymmetrical
growth were more densely distributed close to the
tumor surface as compared to during symmetrical
growth. Changes in the total vessel length during
asymmetrical tumor growth were similar to those
that occurred during symmetrical growth, but the
total vessel length was slightly greater after t=
3,000 h as compared to that during symmetrical
growth.
Fig. 5. Vessel structures over time for the standard case
of symmetrical growth (Smax=0.5). (A) t=1,656 h (spherical
growth stage). (B) t=2,600 h. (C) t=3,200 h.
Fig. 6. Number of branching points versus the ROI, i.e.,
the radial distance between the parent vessel and the
tumor surface.
Fig. 7. Total vessel length over time for the standard case
of symmetrical tumor growth.
A
B
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DISCUSSION
In this study we proposed a new computational
method to simulate tumor angiogenesis in two
dimensions. For the analysis of the spatial distri-
bution of bFGF over time, the bFGF conservation
equation was solved using a finite element
method. Unlike previous studies, we assumed
that the tumor grew over time in our model. This
allowed us to observe the effect of dynamic bFGF
production and its effect on vessel branching
patterns. The brain tumor model proposed by
Kansal et al.
6 was used as a basis for our model
of a growing tumor, which comprised four dis-
tinct stages, namely spherical state, first detectable
lesion, diagnosis, and death. In the present study,
we computed both symmetrical and asymmetrical
tumor growth and compared the results of each.
Biased tumor growth toward vessel branches was
assumed to simulate the asymmetric growth of
the tumor.
From a computational aspect, we used a finite
element method to solve the conservation equa-
tion of bFGF concentrations, whereas a finite
difference method was used in previous studies.
It is widely recognized that the finite element
method is more flexible when dealing with com-
plex geometry. In addition, it is relatively easy to
implement boundary conditions with this method.
However, the finite element method requires
more computing time than the finite difference
method. If a realistic tumor geometry obtained
from magnetic resonance imaging data is adopted
as the computational model, the finite element
method is better suited to solving the equations
for such a complex shape. If the finite element
method that we used is combined with an auto-
matic mesh generation program in a two-dimen-
sional (triangular mesh) or three-dimensional (tet-
rahedron mesh) geometry, a realistic (and there-
fore clinically relevant) tumor can be simulated.
Our model is novel in that we simulated a
tumor that grew and exhibited angiogenic re-
sponses to changing concentrations of bFGF. As
shown in Fig. 7, the number of vessel branches
increased dramatically as soon as a vessel branch
made contact with the tumor surface for the first
time. This can be explained physiologically by the
fact that tumors generally grow rapidly once
blood is supplied to them directly from a parent
vessel; therefore, tumors exhibit a bias in growth
that is skewed towards the parent vessel. To
examine the effect on angiogenesis of such biased
tumor growth, we computed a comparison of
asymmetrical and symmetrical tumor growth. In
the case of symmetrical growth, bFGF was almost
completely consumed at the tumor surface. By
contrast, there were slightly higher concentrations
of bFGF at the tumor surface during asymmetrical
growth, which acted as a promoter that enhanced
the branching of the parent vessel.
Fig. 8. Contours of concentration gradient for bFGF
(relative to bFGF concentration for a tumor radius of 1.0
mm at t=2,590 h) at t=3,000 h for asymmetrical growth.
Fig. 9. Vessel structures over time for the standard case
of symmetrical growth at t=3,200 h.Two-dimensional Model of Tumor Angiogenesis Patterns
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